In murine models of lupus, the administration of IFNα accelerates lupus onset [27], whereas deletion of the gene encoding the type I IFN receptor (IFNAR) leads to a milder, delayed disease [28]. This evidence concerns the gene IFNAR1 and systemic lupus erythematosus.